Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical study

Azilsartan is a novel angiotensin receptor blocker being developed for hypertension treatment. This 16-week, multicenter, randomized, double-blind study compared the efficacy and safety of azilsartan (20–40 mg once daily by forced titration) and its ability to provide 24-h blood pressure (BP) contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rakugi, Hiromi, Enya, Kazuaki, Sugiura, Kenkichi, Ikeda, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348575/
https://www.ncbi.nlm.nih.gov/pubmed/22278628
http://dx.doi.org/10.1038/hr.2012.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348575/
https://www.ncbi.nlm.nih.gov/pubmed/22278628
http://dx.doi.org/10.1038/hr.2012.8

Ejemplares similares